Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center

被引:12
|
作者
Graebner, Allison K. [1 ]
Tarsy, Daniel [1 ]
Shih, Ludy C. [1 ]
Vanderhorst, Veronique [1 ]
Kulkarni, Omesh [1 ]
Kaplan, Scott [1 ]
Simon, David K. [1 ]
机构
[1] Harvard Med Sch, Parkinsons Dis & Movement Disorders Ctr, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Room CLS 638, Boston, MA 02215 USA
关键词
Parkinson's disease; Parkinsonism; DaTscan; Neuroimaging; Biomarker; Nigrostriatal system; Neurodegeneration; DAT-SPECT; DIAGNOSIS; ACCURACY; DISEASE;
D O I
10.1159/000447561
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background/Aims: The clinical diagnosis of degenerative forms of parkinsonism is imperfect, with past studies reporting a high rate of misdiagnosis by neurologists and movement disorder specialists, particularly early in the disease course. 123 I-ioflupane SPECT (DaTscan) is a diagnostic neuro-imaging tool used to distinguish essential tremor from tremor due to degenerative parkinsonisms. The present study expands upon prior studies of the clinical impact of DaTscan imaging in movement disorder centers by assessing quantitative estimates of diagnostic certainty, the impact on subsequent clinical decisions, and the degree to which the asymmetry in the results corresponds to laterality by clinical history and examination. Methods: In a prospective, observational study of the impact of DaTscan imaging in a movement disorder center over the course of 18 months, 4 specialists completed a questionnaire at the time they ordered imaging and again within 1 month after imaging. Results: Twenty-seven patients underwent DaTscan imaging; the result was normal in 4 cases (14.8%), abnormal in 22 cases (81.4%), and equivocal in 1 case (3.7%). In all cases of a normal result, the post-scan-predicted chance of degenerative parkinsonism decreased compared to the pre-scan prediction (p < 0.05), and in all cases of abnormal scan, the postscan chance of degenerative parkinsonism increased or remained high (p < 0.0001). Clinical impacts were observed following imaging in a total of 24 patients (88.9%), including changes in medications for 18 patients and psychological impacts for 11 patients. Asymmetric clinical symptoms were corroborated based on the expected asymmetry of dopamine uptake deficits in 57.1% of the cases, were not present in 23.8%, and were opposite of expectations in 19.0% of the scans. Conclusion: DaTscan imaging results have an impact on physician's confidence in the diagnosis of parkinsonism and may also have a psychological impact on patients. DaTscan imaging may be a useful adjunct to clinical history and examination in selected patients. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [1] The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in parkinsonism induced by pharmaceuticals
    Duran-Ferreras, Eduardo
    Duran-Ferreras, Andres
    REVISTA DE NEUROLOGIA, 2011, 52 (06) : 382 - 383
  • [2] Clinical utility of optimized parameters for a quantitative analysis of 123I-ioflupane SPECT (DaTscan) Images
    Zubal, G.
    Tinaz, S.
    Chow, C.
    Blumenfeld, H.
    Louis, E.
    MOVEMENT DISORDERS, 2017, 32
  • [3] 123I-Ioflupane SPECT in diagnosis of patients with movement disorders
    Paghera, B.
    Premi, E.
    Merli, G.
    Gabanelli, S.
    Lucchini, S.
    Puta, E.
    Magri, G.
    Padovani, A.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S384 - S384
  • [4] Clinical impact of dopamine transporter SPECT imaging using 123I-Ioflupane (DaTSCAN) in patients with clinically uncertain Parkinsonian syndromes
    Tolosa, E
    Catafau, AM
    MOVEMENT DISORDERS, 2002, 17 : S169 - S169
  • [5] Comparing 123I-Ioflupane (DatScan) SPECT using LEHR and Fan-Beam Collimators - an Initial Investigation into Clinical Impact
    Williams, H. A.
    Al-Bahrani, G.
    James, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S543 - S544
  • [6] Thyroid protection before 123I-ioflupane (DaTSCAN) imaging
    Yvan Mouraeff
    Karim Farid
    Xavier Poullias
    Ana Goncalves
    Slavomir Petras
    Nadine Caillat-Vigneron
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 786 - 787
  • [7] Unilateral Absence of the Basal Ganglia on 123I-Ioflupane DaTScan
    Baghdadi, Yaser
    Anh, Se Jin
    Brook, Allan
    Moadel, Renee
    Freeman, Leonard M.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 842 - 843
  • [8] 123I-Ioflupane SPECT in Fahr Disease
    Paghera, Barbara
    Caobelli, Federico
    Giubbini, Raffaele
    JOURNAL OF NEUROIMAGING, 2013, 23 (01) : 157 - 158
  • [9] Thyroid protection before 123I-ioflupane (DaTSCAN) imaging
    Mouraeff, Yvan
    Farid, Karim
    Poullias, Xavier
    Goncalves, Ana
    Petras, Slavomir
    Caillat-Vigneron, Nadine
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (04) : 786 - 787
  • [10] Impact of 123I-Ioflupane SPECT in Patient Management Essential Tremor
    Dellavedova, Luca
    Giorgetti, Andrea
    Maffioli, Lorenzo Stefano
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : E154 - E155